Glaupax, Tabletten

7680384120292 CH-38412 Tabletten

Associated product:

GLAUPAX cpr 250 mg 40 pce
Glaupax, Tabletten
Glaupax, Tabletten
Glaupax, Tabletten
1 / 3
google

Article details

Package size
40
Selling units
40
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/02/2025
Patient information leaflet
Français
28/02/2025
Patient information leaflet
Italien
28/02/2025
Summary of Product Characteristics
Allemand
28/02/2025
Summary of Product Characteristics
Français
28/02/2025
Summary of Product Characteristics
Italien
28/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 17.50
Specialties list
Yes
Generic
No
SL addition date: 01/05/2020

Authorization holder

OmniVision AG

8212 Neuhausen am Rheinfall

Authorization information

Swissmedic authorization number
38412
Drug name
Glaupax, Tabletten
Galenic form
TAB
ATC Code
S01EC01
Authorization status
Z
Dispensing category
B
First authorization
13/01/1975
Authorization expiration date
31/12/9999
IT Number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Package details

Description (FR)
GLAUPAX cpr 250 mg 40 pce
Description (DE)
GLAUPAX Tabl 250 mg 40 Stk
Market launch
13/01/1975
Narcotic (BTM)
No

Other package sizes (2)

None
10 TABL
GTIN: None
Not in V1
GLAUPAX cpr 250 mg 100 pce
100 TABL
GTIN: 7680384120278
View